recall
Alert: Macleod's Pharmaceuticals recalls Losartan Potassium and Losartan Potassium/Hydrochlorothiazide Combination tablets
Presence of NMBA (N-Nitroso-N
recall
Alert: RXQ Compounding recalls all sterile human and animal products due to lack of sterility process assurance
Lack of sterility process assurance
recall
Alert: Premier Pharmacy Labs recalls all sterile products due to lack of sterility assurance
Lack of sterility assurance
recall
Alert: Losartan Potassium Tablets USP 50mg & 100mg - Expanded
Presence of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)
recall
Alert: Losartan Potassium 25 mg, 50 mg and 100 mg Tablets
Presence of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA)
recall
Alert: Losartan Potassium 25 mg and 100 mg Tablets
Possible presence of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA)
recall
Alert: Losartan Potassium Tablets USP 50mg - Expanded
Trace amounts of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA)
recall
Alert: Fentanyl Transdermal System
Product mislabeling; cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches
recall
Alert: Losartan Potassium Tablets USP 25mg, 50mg, and 100mg - Expanded
Trace amounts of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA)
recall
Alert: Hospira, Inc. 8.4% Sodium Bicarbonate Injection, USP
Presence of particulate matter, confirmed as glass
recall
Alert: Stokes Healthcare Pilocarpine 0.1% Ophthalmic Solution
Presence of high level of preservative benzalkonium chloride
recall
Alert: Norbrook Laboratories Enroflox 100 Injection (enrofloxacin)
Product sterility cannot be assured.
recall
Alert: Norbrook Laboratories Noromectin Injection (ivermectin)
Product sterility cannot be assured.
recall
Alert: Norbrook Laboratories Ivermax 1% Injection (ivermectin)
Product sterility cannot be assured.
recall
Alert: American Health Packaging Valsartan Tablets, USP, 160 mg
Presence of probable human carcinogen N-Nitrosodiethylamine
recall
Alert: Torrent Pharmaceuticals Losartan Potassium Tablets, USP and Losartan Potassium /Hydrochlorothiazide Tablets, USP (Expanded Recall)
Presence of N-Methylnitrosobutyric acid
recall
Alert: Aurobindo Pharma/ScieGen Pharmaceuticals Irbesartan
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Camber Pharmaceuticals Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg
Presence of potential carcinogen N-Nitroso N-Methyl 4-amino butyric acid
recall
Alert: AurobindoPharma Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP (Expanded Recall)
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: AurobindoPharma Acetris Valsartan Tablets, USP
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Macleods Pharmaceuticals Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg
Presence of probable carcinogen N-nitrosodiethylamine
